Item 5.07 Submission of Matters to a Vote of Security Holders.

On October 13, 2022, CorMedix Inc. (the "Company") held its Annual Meeting of the Stockholders of the Company (the "Annual Meeting"). Holders of shares of the Company's common stock, Series E Preferred Stock and Series G Preferred Stock were entitled to vote at the Annual Meeting.

For more information about the foregoing proposals, please see the proxy statement filed by the Company with the Securities and Exchange Commission on August 30, 2022 (the "Proxy Statement"). The Company's stockholders voted on the following four proposals at the Annual Meeting, casting their votes as described below.

Proposal No. 1 - Election of Directors. The following individuals, each of whom was named as a nominee in the Proxy Statement, were elected by the Company's stockholders by a plurality of votes cast to serve on the Company's board of directors until the Company's 2023 annual meeting of stockholders. Information on the vote relating to each director standing for election is set forth below:





Nominee                FOR          WITHHELD        BROKER NON-VOTES
Paulo F. Costa       7,728,425       2,842,846          19,076,853
Janet Dillione       8,809,412       1,761,859          19,076,853
Gregory Duncan       8,772,532       1,798,739          19,076,853
Alan W. Dunton       8,752,880       1,818,391          19,076,853
Myron Kaplan         8,785,716       1,785,555          19,076,853
Steven Lefkowitz     9,243,754       1,327,517          19,076,853
Joseph Todisco       7,566,786       3,004,485          19,076,853



Proposal No. 2 - Advisory Vote on Executive Compensation. Proposal No. 2 was to approve, on an advisory basis, the compensation paid to the Company's Named Executive Officers, as disclosed in the Proxy Statement. The proposal was approved. The results of the vote taken were as follows:





   FOR       AGAINST    ABSTAIN   BROKER NON-VOTES
8,041,682   2,406,462   123,127      19,076,853



Proposal No. 3 - Approval of Amendment and Restatement of the 2019 Omnibus Stock Incentive Plan. Proposal No. 3 was for the Company's stockholders to approve an amendment and restatement of the Company's 2019 Omnibus Stock Incentive Plan. The proposal was approved. The results of the vote taken were as follows:





   FOR       AGAINST    ABSTAIN   BROKER NON-VOTES
8,110,236   2,308,931   152,104      19,076,853





Proposal No. 4 - Ratification of Appointment of Auditors. Proposal No. 4 was to ratify the appointment of Friedman LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. The proposal was approved. The results of the vote taken were as follows:





   FOR        AGAINST    ABSTAIN
27,961,029   1,579,888   107,207




                                       1

© Edgar Online, source Glimpses